2023 international evidence-based guideline pcos glp-1 receptor agonist Efficacy and safety of agonists on weight management and metabolic parameters in women: a meta-analysis of randomized controlled trials Perioperative management of patients taking
Description
Tirzepatide: SURMOUNT trial results The SURMOUNT program represents the largest clinical trial dataset for tirzepatide weight loss
Given the risk of complications from uncontrolled diabetes, such as the increased risk of wound infections from hyperglycemia, it would be in a patients best interest to continue these medications in the perioperative setting
Key points Medicare Part D doesnt cover weight loss medications when used only for weight loss
For patients with severe obesity and metabolic disease, they save lives
